ESR1 and cancer: Approximately 70–80% of breast cancers are hormone-dependent; their growth is stimulated in response to the hormone estrogen, with the majority of these estrogen receptor positive (ER+) cancers also expressing the progesterone receptor (ER+/PR+ cancers).